Amit Hazan
Stock Analyst at Goldman Sachs
(2.08)
# 2,990
Out of 5,131 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $96.93 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $7.75 | -67.74% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.51 | +1,158.28% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $18.99 | -57.87% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $62.38 | +0.99% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $202.74 | +34.16% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $17.50 | -2.86% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $5.57 | +7,709.69% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $31.33 | +40.44% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $83.01 | -12.06% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $20.15 | +163.03% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $26.95 | +111.50% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $17.59 | -45.99% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $124.64 | -16.56% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $19.80 | +203.03% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $96.95 | +18.62% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $361.37 | -58.49% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $95.72 | -51.94% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $572.75 | -57.80% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $91.45 | +93.55% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $209.72 | -29.91% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $0.87 | +347.45% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $96.93
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $7.75
Upside: -67.74%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.51
Upside: +1,158.28%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $18.99
Upside: -57.87%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $62.38
Upside: +0.99%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $202.74
Upside: +34.16%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $17.50
Upside: -2.86%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $5.57
Upside: +7,709.69%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $31.33
Upside: +40.44%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $83.01
Upside: -12.06%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $20.15
Upside: +163.03%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $26.95
Upside: +111.50%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $17.59
Upside: -45.99%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $124.64
Upside: -16.56%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $19.80
Upside: +203.03%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $96.95
Upside: +18.62%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $361.37
Upside: -58.49%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $95.72
Upside: -51.94%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $572.75
Upside: -57.80%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $91.45
Upside: +93.55%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $209.72
Upside: -29.91%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $0.87
Upside: +347.45%